ORIC today
$8.71-$0.29 (-3.28%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourDescending Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $7.23
Key levels
Resistance$11.16
Resistance$10.13
Support$8.46
Support$7.36
Latest news & SEC filings
AnalystH.C. Wainwright keeps Buy rating and $27 target on ORIC Pharmaceuticals
AnalystBTIG Reiterates Buy Rating on ORIC Pharmaceuticals With $26 Price Target
All ORIC news →About Oric Pharmaceuticals
This biopharma firm creates medicines aimed at cancers that stop responding to treatment. Its two main drug candidates are rinzimetostat, tested in advanced prostate cancer, and enozertinib, tested in lung cancer with specific EGFR mutations. Research and trials take place in the United States and South Korea.
Based on the company's 10-K filed Feb 23, 2026.
Nasdaq · Healthcare
Oric Pharmaceuticals, Inc. (ORIC)
What Is the Price Target for ORIC?
SEPT Low Target
$21.25
SEPT Mid Target
$25.00
SEPT High Target
$28.75
Analyst Consensus
$25.00
Is ORIC a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ORIC.
Start Free Trial →Is ORIC Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$22.82
17
Moat Score
NONE
4/9
Piotroski Score
23.5
Altman Z-Score
What Is Smart Money Doing with ORIC?
Insider Signal
SELLING
0 buys / 7 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Piscitelli Dominic | officer | Buy | 14,000 | $61K | Oct 20, 2026 |
| Piscitelli Dominic | officer | Sale | 14,000 | $189K | Oct 20, 2026 |
| Heyman Richard A. | director | Buy | 3,500 | $6K | Oct 1, 2026 |
| Heyman Richard A. | director | Sale | 3,500 | $45K | Oct 1, 2026 |
| Heyman Richard A. | director | Sale | 3,200 | $41K | Oct 1, 2026 |
| Piscitelli Dominic | officer | Buy | 13,400 | $58K | Sep 28, 2026 |
| Piscitelli Dominic | officer | Sale | 13,400 | $181K | Sep 28, 2026 |
| Piscitelli Dominic | officer | Buy | 52,000 | $227K | Aug 26, 2026 |
| Piscitelli Dominic | officer | Buy | 25,000 | $150K | Aug 26, 2026 |
| Piscitelli Dominic | officer | Sale | 77,000 | $1.1M | Aug 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ORIC Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
19.67%
FCF Growth YoY
1.9%
Revenue Trend
UNKNOWN
Dark Pool Trades for ORIC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ORIC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:10:33 | $8.78 | 1,000 | $$9K | BUY |
| 16:57:56 | $8.79 | 1,000 | $$9K | BUY |
| 16:56:32 | $8.80 | 1,000 | $$9K | BUY |
| 16:56:06 | $8.78 | 1,250 | $$11K | SELL |
| 16:49:02 | $8.78 | 2,500 | $$22K | BUY |
5 dark pool trades shown · $$59K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About ORIC
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ORIC. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $ORIC (Oric Pharmaceuticals, Inc.) Price: $8.31 | Zone: $7.46 to $8.50 Conviction: HIGH | Analyst upside: +153% Near resistance (90% of range) — breakout watch. Strong positive news (4...
Join 3,500+ traders discussing ORIC in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Oric Pharmaceuticals, Inc. (ORIC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ORIC — frequently asked questions
What is ORIC stock price today?
Oric Pharmaceuticals, Inc. (ORIC) is at $8.71, down 3.28% (-$0.29) at the Nov 12, 2026 close.
Why is ORIC stock moving today?
Latest ORIC news — Oct 28, 2026: H.C. Wainwright keeps Buy rating and $27 target on ORIC Pharmaceuticals · Oct 28, 2026: BTIG Reiterates Buy Rating on ORIC Pharmaceuticals With $26 Price Target
What is the ORIC price target?
The average analyst price target for ORIC is $25.00, ranging from $16 to $27, based on 7 analysts. Latest: Leerink Partners initiates on Oct 5, 2026.
What do analysts rate ORIC?
Analyst ratings for ORIC: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did ORIC beat earnings?
ORIC last reported on Aug 3, 2026: EPS -$0.38 vs -$0.36 expected — a miss of 5.7%.
Does ORIC pay a dividend?
ORIC does not currently pay a dividend.
What are ORIC support and resistance levels?
Support: $8.46, $7.36. Resistance: $10.13, $11.16, $12.76.
What are insiders doing with ORIC?
Insider activity: SELLING, 0 buys and 7 sells in the last 90 days.
What is the latest news on ORIC?
Oct 28, 2026: H.C. Wainwright keeps Buy rating and $27 target on ORIC Pharmaceuticals · Oct 28, 2026: BTIG Reiterates Buy Rating on ORIC Pharmaceuticals With $26 Price Target